Our hosts start by discussing the 901 trial before moving into a discussion about bladder preservation and the importance of being multi-disciplinary.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers.

Learn more about The View on GU: https://theviewongu.com

This podcast has been made possible through financial support by Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Ipsen, Merck, Novartis, Pfizer and TerSera.